Ruth Salmon
Vice President - Preclinical Sciences Bristol Myers Squibb
Seminars
Tuesday 15th September 2026
Panel Discussion: Investigating the Evolution of In Vivo Therapies to Accelerate Innovations
9:30 am
- Discussing the rapid progression of in vivo therapies, considering the impact on COGs and patient outcomes
- Highlighting in vivo innovations to develop more effective, scalable, and accessible therapies
- Evaluating what’s next for in vivo therapies to understand anticipated clinical progress, expanding disease indications and projected advancements for strategic planning
